Tilray Brands (NASDAQ:TLRY) Price Target Lowered to $9.00 at ATB Cormark Capital Markets

Tilray Brands (NASDAQ:TLRY) had its price target lowered by ATB Cormark Capital Markets from $9.50 to $9.00 in a research report issued to clients and investors on Thursday,BayStreet.CA reports. The firm presently has a “sector perform” rating on the stock. ATB Cormark Capital Markets’ price objective would suggest a potential upside of 36.88% from the stock’s current price.

TLRY has been the subject of a number of other reports. Canaccord Genuity Group assumed coverage on shares of Tilray Brands in a report on Tuesday, January 27th. They set a “hold” rating for the company. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Tilray Brands in a report on Wednesday, January 21st. TD Cowen cut their price objective on Tilray Brands from $10.00 to $7.00 and set a “buy” rating for the company in a research report on Monday. Wall Street Zen raised Tilray Brands from a “sell” rating to a “hold” rating in a research note on Saturday, March 21st. Finally, Zacks Research upgraded Tilray Brands from a “strong sell” rating to a “hold” rating in a report on Wednesday, February 11th. Three research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $11.20.

Tilray Brands Price Performance

NASDAQ TLRY traded up $0.44 on Thursday, reaching $6.58. The company’s stock had a trading volume of 4,443,714 shares, compared to its average volume of 3,679,706. Tilray Brands has a twelve month low of $3.51 and a twelve month high of $23.20. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.72 and a current ratio of 2.81. The firm’s 50 day moving average is $7.37 and its two-hundred day moving average is $10.25. The stock has a market cap of $766.03 million, a PE ratio of -0.30 and a beta of 1.96.

Tilray Brands (NASDAQ:TLRY) last announced its quarterly earnings data on Wednesday, April 1st. The company reported ($0.24) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by ($0.10). Tilray Brands had a negative return on equity of 6.35% and a negative net margin of 251.69%.The business had revenue of $206.73 million during the quarter, compared to analyst estimates of $201.35 million. During the same period in the prior year, the firm earned ($0.87) EPS. As a group, sell-side analysts predict that Tilray Brands will post -0.2 EPS for the current year.

Hedge Funds Weigh In On Tilray Brands

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Hilton Head Capital Partners LLC purchased a new stake in shares of Tilray Brands in the fourth quarter valued at $38,000. Schonfeld Strategic Advisors LLC raised its position in Tilray Brands by 4.5% during the fourth quarter. Schonfeld Strategic Advisors LLC now owns 144,358 shares of the company’s stock valued at $1,304,000 after buying an additional 6,182 shares during the period. IFP Advisors Inc lifted its stake in Tilray Brands by 14.3% in the 4th quarter. IFP Advisors Inc now owns 60,318 shares of the company’s stock worth $545,000 after acquiring an additional 7,541 shares in the last quarter. Integrated Wealth Concepts LLC boosted its position in Tilray Brands by 33.8% during the 3rd quarter. Integrated Wealth Concepts LLC now owns 36,977 shares of the company’s stock worth $64,000 after acquiring an additional 9,341 shares during the period. Finally, CreativeOne Wealth LLC grew its stake in Tilray Brands by 12.2% during the 3rd quarter. CreativeOne Wealth LLC now owns 87,134 shares of the company’s stock valued at $151,000 after acquiring an additional 9,452 shares in the last quarter. 9.35% of the stock is currently owned by hedge funds and other institutional investors.

Tilray Brands News Roundup

Here are the key news stories impacting Tilray Brands this week:

• Positive Sentiment: Record revenue, international cannabis strength and profit improvement — Tilray reported ~11% y/y revenue growth to ~$207M, gross profit expanded and international cannabis/net flower volumes were notably strong, driving the top‑line beat and underpinning the upbeat reaction. GlobeNewswire: Record Q3 Results
• Positive Sentiment: Company reaffirmed full‑year guidance after the quarter, which reduces near‑term uncertainty and helped lift sentiment despite mixed margin commentary. MSN: Reaffirms Outlook
• Positive Sentiment: Analyst upgrade — Roth MKM raised TLRY from Neutral to Buy with a $10 price target, signaling upside from current levels and likely contributing to buying interest. Benzinga: Roth MKM Upgrade
• Positive Sentiment: Strategic M&A and brand partnerships — the company is expanding beverage and global craft beverage presence (BrewDog acquisition referenced in the release) and has a Popsicle RTD partnership that supports beverage pipeline upside over time. InsiderMonkey: Partnership Coverage
• Neutral Sentiment: Earnings call details available — the full transcript and management commentary provide color on margins, international strategy and beverage execution for investors doing deeper due diligence. Seeking Alpha: Earnings Call Transcript
• Neutral Sentiment: Positive screen/social coverage — TLRY is appearing on “best marijuana stocks” lists, which may help retail interest but has uncertain timing/impact. Yahoo: Stock List Inclusion
• Negative Sentiment: EPS miss and continued net loss — TLRY reported a ($0.24) EPS, missing consensus by ~$0.10 despite the revenue beat; the lingering loss keeps profitability concerns front-and-center for analysts. Zacks: Q3 Loss, Revenue Beat
• Negative Sentiment: Beverage segment weakness, margin pressure and competition — investors are focused on beverage execution and rising competition, which helped trigger an intraday selloff despite record revenue. Yahoo: Reasons for Selloff
• Negative Sentiment: Analyst downgrades and lower expectations — some firms cut forecasts or ratings (TD Cowen noted lower expectations; at least one downgrade earlier pushed shares down), adding headwinds to sentiment. AmericanBankingNews: Analyst Actions

About Tilray Brands

Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.

Tilray’s product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.